Details of the Drug

General Information of Drug (ID: DMF6EAZ)

Drug Name

JNJ-80948543

Synonyms

JNJ-8543

Indication

Disease Entry	ICD 11	Status	REF
Haematological malignancy	2B33.Y	Phase 1	[1]
------------------------------------------------------------------------------------

Cross-matching ID

References

1	ClinicalTrials.gov (NCT05424822) A Phase 1, First-in-human Study of JNJ-80948543, a T-cell Redirecting Antibody, in Participants With NHL and CLL. U.S.National Institutes of Health.